{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-005165","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2026-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.639492+00:00","generated_at":"2026-05-16T09:44:35.165173+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ABVC BioPharma completes $2.28M additional unregistered offering, issues 1.5M shares","bullets":["From May 26, 2025 to Jan 6, 2026, ABVC accepted additional subscriptions totaling $2,275,468 under same terms as prior Reg S offering.","Issued 1,500,250 shares of common stock at prices ranging from $1.00 to $1.95 per share.","Shares represent approximately 5.92% of outstanding common stock as of filing date.","All purchasers are non-U.S. persons (accredited investors); voting rights transferred to Chairman Eugene Jiang via proxy agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-005165","json":"https://secwatch.observer/filing/0001213900-26-005165.json","markdown":"https://secwatch.observer/filing/0001213900-26-005165.md","text":"https://secwatch.observer/filing/0001213900-26-005165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/0001213900-26-005165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/ea0272768-8ka1_abvc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:44:35.165173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}